biotech deals

Realistic white price tags collection Special offer or shopping discount label
Favicon Fierce Biotech

China biotechs ‘reshaping’ US biopharma: Jefferies report

In 2025's Q1, 32% of outlicensing biotech deal value occurred in China versus 21% reported in both 2024 and 2023, according to Jefferies.
Gabrielle Masson Jul 14, 2025 2:30pm
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Trump investment policy could hit US-China biotech dealmaking

Feb 28, 2025 2:45pm
mergers acquisitions

Lilly, Merck bet billions in biobucks on peptide-based delivery

Jan 3, 2023 8:40am